Oral Sessions最新文献

筛选
英文 中文
55 Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization study 55 637 种人体代谢物与卵巢癌之间的因果关系:亡羊补牢式随机研究
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.40
Yedong Huang, Wenyu Lin, Xiangqin Zheng
{"title":"55 Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization study","authors":"Yedong Huang, Wenyu Lin, Xiangqin Zheng","doi":"10.1136/ijgc-2024-esgo.40","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.40","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"40 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140401009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
738 Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer – analysis of the international CCTG CX.5/SHAPE phase III trial 738 低风险宫颈癌的手术方法、术前 LEEP/锥形活检与复发和死亡模式--国际 CCTG CX.5/SHAPE III 期试验分析
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.19
Sven Mahner, F. Trillsch, Janice S Kwon, Sarah Ferguson, Paul Bessette, Gwenael Ferron, A. Maulard, Cor De Kroon, Willemien JVan Driel, John Tidy, Karin Williamson, Frédéric Goffin, Stephan Polterauer, Brynhildur Eyjolsdottir, Jae-Weon Kim, Patrick J Maguire, Barbara Schmalfeldt, Dongsheng Tu, Lois E Shepherd, Marie Plante
{"title":"738 Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer – analysis of the international CCTG CX.5/SHAPE phase III trial","authors":"Sven Mahner, F. Trillsch, Janice S Kwon, Sarah Ferguson, Paul Bessette, Gwenael Ferron, A. Maulard, Cor De Kroon, Willemien JVan Driel, John Tidy, Karin Williamson, Frédéric Goffin, Stephan Polterauer, Brynhildur Eyjolsdottir, Jae-Weon Kim, Patrick J Maguire, Barbara Schmalfeldt, Dongsheng Tu, Lois E Shepherd, Marie Plante","doi":"10.1136/ijgc-2024-esgo.19","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.19","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"63 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140401594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
849 Risk-reducing prophylactic fimbriectomy followed by delayed ooforectomy in women at risk of ovarian cancer: results of a single-center retrospective analysis 849 对有卵巢癌风险的妇女进行降低风险的预防性膀胱切除术,然后进行延迟卵巢切除术:单中心回顾性分析的结果
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.52
Mathilde Duchatelet, Julie Alline, Séverine Risbourg, Timothée Choteau, Audrey Mailliez, Camille Pasquesoone, Delphine Hudry, Fabrice Narducci, M. Deley, Carlos Martinez-Gómez
{"title":"849 Risk-reducing prophylactic fimbriectomy followed by delayed ooforectomy in women at risk of ovarian cancer: results of a single-center retrospective analysis","authors":"Mathilde Duchatelet, Julie Alline, Séverine Risbourg, Timothée Choteau, Audrey Mailliez, Camille Pasquesoone, Delphine Hudry, Fabrice Narducci, M. Deley, Carlos Martinez-Gómez","doi":"10.1136/ijgc-2024-esgo.52","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.52","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"86 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
186 Compliance with follow-up after low-grade cervical smear results and the long term risk of developing cervical cancer 186 宫颈涂片结果为低分级后的随访依从性与罹患宫颈癌的长期风险
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.5
R. Bekkers, Renee FM Ebisch, Bert Siebers, Johannes Bulten, K. Houkes
{"title":"186 Compliance with follow-up after low-grade cervical smear results and the long term risk of developing cervical cancer","authors":"R. Bekkers, Renee FM Ebisch, Bert Siebers, Johannes Bulten, K. Houkes","doi":"10.1136/ijgc-2024-esgo.5","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.5","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"239 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
587 Effect of substantial lymphovascular space invasion on patterns of first recurrence in FIGO 2009 surgical stage I endometrioid endometrial adenocarcinoma 587 淋巴管间隙实质性侵犯对 FIGO 2009 手术 I 期子宫内膜样腺癌首次复发模式的影响
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.30
Christian Dagher, P. B. Trent, Rofieda R Alwaqfi, Lora Hedrick Ellenson, Ben Davidson, Qin Zhou, A. Iasonos, Jennifer J Mueller, K. Alektiar, V. Makker, Mario M Leitao, Ane Gerda Z Eriksson, N. Abu-Rustum
{"title":"587 Effect of substantial lymphovascular space invasion on patterns of first recurrence in FIGO 2009 surgical stage I endometrioid endometrial adenocarcinoma","authors":"Christian Dagher, P. B. Trent, Rofieda R Alwaqfi, Lora Hedrick Ellenson, Ben Davidson, Qin Zhou, A. Iasonos, Jennifer J Mueller, K. Alektiar, V. Makker, Mario M Leitao, Ane Gerda Z Eriksson, N. Abu-Rustum","doi":"10.1136/ijgc-2024-esgo.30","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.30","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"26 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140404021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
256 Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer from the CCTG CX.5 ‘SHAPE’ phase III clinical trial 256 CCTG CX.5 "SHAPE "III 期临床试验对早期宫颈癌单纯子宫切除术与根治性子宫切除术的成本效益分析
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.9
Janice S Kwon, Marie Plante, Sarah Ferguson, Helen Mctaggart-Cowan, Vanessa Samouëlian, Gwenael Ferron, A. Maulard, Eris Lambaudie, John Tidy, Karin Williamson, Noreen Gleeson, Lori Brotto, Shirley Yeung, Navdeep Khabra, R. Pataky, Kelvin Chan, Matthew Cheung, Juliana Ubi, Dongsheng Tu, Lois E Shepherd
{"title":"256 Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer from the CCTG CX.5 ‘SHAPE’ phase III clinical trial","authors":"Janice S Kwon, Marie Plante, Sarah Ferguson, Helen Mctaggart-Cowan, Vanessa Samouëlian, Gwenael Ferron, A. Maulard, Eris Lambaudie, John Tidy, Karin Williamson, Noreen Gleeson, Lori Brotto, Shirley Yeung, Navdeep Khabra, R. Pataky, Kelvin Chan, Matthew Cheung, Juliana Ubi, Dongsheng Tu, Lois E Shepherd","doi":"10.1136/ijgc-2024-esgo.9","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.9","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"124 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
403 Primary results from ENGOT-Ov41/GEICO 69-O/ANITA, a double-blind placebo-controlled phase 3 trial evaluating atezolizumab combined with platinum-based chemotherapy and maintenance niraparib for recurrent ovarian cancer with a platinum-free interval >6 months 403 ENGOT-Ov41/GEICO 69-O/ANITA的初步结果,这是一项双盲安慰剂对照3期试验,评估了atezolizumab联合铂类化疗和维持性尼拉帕尼治疗无铂间隔大于6个月的复发性卵巢癌的效果
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.44
Antonio González-Martín, M. J. Rubio-Pérez, Florian Heitz, R. Christensen, N. Colombo, T. Gorp, A. Oaknin, Alexandra Leary, Lydia Gaba, C. Lebreton, Luis Miguel De Sande González, M. Romeo, A. Redondo, M. Barretina-Ginesta, Alejandro Pérez-Fidalgo, A. Santaballa, María José Bermejo, I. Bruchim, I. Ray-Coquard, Frédéric Selle
{"title":"403 Primary results from ENGOT-Ov41/GEICO 69-O/ANITA, a double-blind placebo-controlled phase 3 trial evaluating atezolizumab combined with platinum-based chemotherapy and maintenance niraparib for recurrent ovarian cancer with a platinum-free interval >6 months","authors":"Antonio González-Martín, M. J. Rubio-Pérez, Florian Heitz, R. Christensen, N. Colombo, T. Gorp, A. Oaknin, Alexandra Leary, Lydia Gaba, C. Lebreton, Luis Miguel De Sande González, M. Romeo, A. Redondo, M. Barretina-Ginesta, Alejandro Pérez-Fidalgo, A. Santaballa, María José Bermejo, I. Bruchim, I. Ray-Coquard, Frédéric Selle","doi":"10.1136/ijgc-2024-esgo.44","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.44","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"69 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
260 ViRP signature predicts response to treatment with chemotherapy and bevacizumab in ovarian cancer – a translational study of the ICON-7 trial’ 260 ViRP特征预测卵巢癌患者对化疗和贝伐单抗治疗的反应--ICON-7试验的转化研究
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.54
Kristina Lindemann, Mads H Haugen, Jacobus Pfisterer, G. Mælandsmo, Stefan Kommoss, O. Lingjærde, Florian Heitz, J. Sehouli, Rainer Kimmig, B. Winterhoff, O. Engebraaten
{"title":"260 ViRP signature predicts response to treatment with chemotherapy and bevacizumab in ovarian cancer – a translational study of the ICON-7 trial’","authors":"Kristina Lindemann, Mads H Haugen, Jacobus Pfisterer, G. Mælandsmo, Stefan Kommoss, O. Lingjærde, Florian Heitz, J. Sehouli, Rainer Kimmig, B. Winterhoff, O. Engebraaten","doi":"10.1136/ijgc-2024-esgo.54","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.54","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"50 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
521 Safety and efficacy of Durvalumab (D) + Tremelimumab (T) + Metronomic Oral Vinorelbine (MOV) in patients with recurrent/metastatic cervical cancer (RMCC) in the MOVIE trial 521 MOVIE试验中Durvalumab(D)+ Tremelimumab(T)+Metronomic Oral Vinorelbine(MOV)治疗复发性/转移性宫颈癌(RMCC)患者的安全性和有效性
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.14
J-S. Frenel, Laurent Mathiot, Edith Bocorman, Alice Hervieu, E. Coquan, T. D. M. Rouge, E. Saâda-Bouzid, Renaud Sabatier, P. Lavaud, F. Legrand, C. Cropet, Emmanuelle Charaffe, Anthony Goncalves
{"title":"521 Safety and efficacy of Durvalumab (D) + Tremelimumab (T) + Metronomic Oral Vinorelbine (MOV) in patients with recurrent/metastatic cervical cancer (RMCC) in the MOVIE trial","authors":"J-S. Frenel, Laurent Mathiot, Edith Bocorman, Alice Hervieu, E. Coquan, T. D. M. Rouge, E. Saâda-Bouzid, Renaud Sabatier, P. Lavaud, F. Legrand, C. Cropet, Emmanuelle Charaffe, Anthony Goncalves","doi":"10.1136/ijgc-2024-esgo.14","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.14","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"189 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer 237 InnovaTV 301/ENGOT-Cx12/GOGG-3057:一项针对2L或3L复发性或转移性宫颈癌的替索单抗维多汀与研究者选择的化疗方案的全球性、随机、开放标签3期研究
Oral Sessions Pub Date : 2024-03-01 DOI: 10.1136/ijgc-2024-esgo.7
Antonio Gonzalez Martín, B. Slomovitz, K. Fujiwara, E. Kalbacher, A. Bagameri, S. Ghamande, Jung-Yun Lee, S. Banerjee, F.C. Maluf, Domenica Lorusso, K. Yonemori, E. Nieuwenhuysen, Luis Manso Sánchez, L. Woelber, A.M. Westermann, A. Covens, E. Whalley, Melinda Siew Leng Teng, I. Soumaoro, I. Vergote
{"title":"237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer","authors":"Antonio Gonzalez Martín, B. Slomovitz, K. Fujiwara, E. Kalbacher, A. Bagameri, S. Ghamande, Jung-Yun Lee, S. Banerjee, F.C. Maluf, Domenica Lorusso, K. Yonemori, E. Nieuwenhuysen, Luis Manso Sánchez, L. Woelber, A.M. Westermann, A. Covens, E. Whalley, Melinda Siew Leng Teng, I. Soumaoro, I. Vergote","doi":"10.1136/ijgc-2024-esgo.7","DOIUrl":"https://doi.org/10.1136/ijgc-2024-esgo.7","url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"71 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140286386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信